Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Using climate-FVS to project landscape-level forest carbon stores for 100 years from field and LiDAR measures of initial conditions.

Gálvez FB, Hudak AT, Byrne JC, Crookston NL, Keefe RF.

Carbon Balance Manag. 2014 Feb 4;9(1):1. doi: 10.1186/1750-0680-9-1.

2.

Btk regulates macrophage polarization in response to lipopolysaccharide.

Ní Gabhann J, Hams E, Smith S, Wynne C, Byrne JC, Brennan K, Spence S, Kissenpfennig A, Johnston JA, Fallon PG, Jefferies CA.

PLoS One. 2014 Jan 21;9(1):e85834. doi: 10.1371/journal.pone.0085834. eCollection 2014.

3.

Estrogen receptor α regulates tripartite motif-containing protein 21 expression, contributing to dysregulated cytokine production in systemic lupus erythematosus.

Smith S, Ní Gabhann J, McCarthy E, Coffey B, Mahony R, Byrne JC, Stacey K, Ball E, Bell A, Cunnane G, Doran MF, Molloy ES, Lee RZ, Harvey B, Kearns G, Jefferies CA.

Arthritis Rheumatol. 2014 Jan;66(1):163-72. doi: 10.1002/art.38187.

4.

Bruton's tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin.

Byrne JC, Ní Gabhann J, Stacey KB, Coffey BM, McCarthy E, Thomas W, Jefferies CA.

J Immunol. 2013 May 15;190(10):5207-15. doi: 10.4049/jimmunol.1300057. Epub 2013 Apr 17.

5.

Genetics of SLE: functional relevance for monocytes/macrophages in disease.

Byrne JC, Ní Gabhann J, Lazzari E, Mahony R, Smith S, Stacey K, Wynne C, Jefferies CA.

Clin Dev Immunol. 2012;2012:582352. doi: 10.1155/2012/582352. Epub 2012 Oct 16. Review.

6.

Fibroblast growth factor homologous factor 1 interacts with NEMO to regulate NF-κB signaling in neurons.

König HG, Fenner BJ, Byrne JC, Schwamborn RF, Bernas T, Jefferies CA, Prehn JH.

J Cell Sci. 2012 Dec 15;125(Pt 24):6058-70. doi: 10.1242/jcs.111880. Epub 2012 Oct 24.

7.

Defects in acute responses to TLR4 in Btk-deficient mice result in impaired dendritic cell-induced IFN-γ production by natural killer cells.

Ní Gabhann J, Spence S, Wynne C, Smith S, Byrne JC, Coffey B, Stacey K, Kissenpfennig A, Johnston J, Jefferies CA.

Clin Immunol. 2012 Mar;142(3):373-82. doi: 10.1016/j.clim.2011.12.009. Epub 2011 Dec 28.

PMID:
22281426
8.

IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia.

Coss KP, Byrne JC, Coman DJ, Adamczyk B, Abrahams JL, Saldova R, Brown AY, Walsh O, Hendroff U, Carolan C, Rudd PM, Treacy EP.

Mol Genet Metab. 2012 Feb;105(2):212-20. doi: 10.1016/j.ymgme.2011.10.018. Epub 2011 Nov 7.

PMID:
22133299
9.

Proteomic analysis of coronary sinus serum reveals leucine-rich α2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure.

Watson CJ, Ledwidge MT, Phelan D, Collier P, Byrne JC, Dunn MJ, McDonald KM, Baugh JA.

Circ Heart Fail. 2011 Mar;4(2):188-97. doi: 10.1161/CIRCHEARTFAILURE.110.952200. Epub 2011 Jan 31.

PMID:
21282491
10.

Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer.

Fan Y, Murphy TB, Byrne JC, Brennan L, Fitzpatrick JM, Watson RW.

J Proteome Res. 2011 Mar 4;10(3):1361-73. doi: 10.1021/pr1011069. Epub 2011 Jan 27.

PMID:
21166384
11.

Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.

Bones J, Byrne JC, O'Donoghue N, McManus C, Scaife C, Boissin H, Nastase A, Rudd PM.

J Proteome Res. 2011 Mar 4;10(3):1246-65. doi: 10.1021/pr101036b. Epub 2011 Jan 19.

PMID:
21142185
12.

Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia.

Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM.

J Proteome Res. 2010 Sep 3;9(9):4476-89. doi: 10.1021/pr1002356. Erratum in: J Proteome Res. 2010 Oct 1;9(10):5510.

PMID:
20578731
13.

Galactosemia, a single gene disorder with epigenetic consequences.

Coman DJ, Murray DW, Byrne JC, Rudd PM, Bagaglia PM, Doran PD, Treacy EP.

Pediatr Res. 2010 Mar;67(3):286-92. doi: 10.1203/PDR.0b013e3181cbd542.

PMID:
19952866
14.

Widespread increase of tree mortality rates in the western United States.

van Mantgem PJ, Stephenson NL, Byrne JC, Daniels LD, Franklin JF, Fulé PZ, Harmon ME, Larson AJ, Smith JM, Taylor AH, Veblen TT.

Science. 2009 Jan 23;323(5913):521-4. doi: 10.1126/science.1165000.

15.

2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.

Byrne JC, Downes MR, O'Donoghue N, O'Keane C, O'Neill A, Fan Y, Fitzpatrick JM, Dunn M, Watson RW.

J Proteome Res. 2009 Feb;8(2):942-57. doi: 10.1021/pr800570s.

PMID:
19093873
16.

Fasting status as a consideration for human serum collection and preparation prior to depletion and analysis.

Byrne JC, Downes MR, O'Donoghue N, Fitzpatrick JM, Dunn MJ, Watson RW.

Electrophoresis. 2008 Jul;29(14):3055-9. doi: 10.1002/elps.200700933.

PMID:
18551713
17.

Urinary markers for prostate cancer.

Downes MR, Byrne JC, Pennington SR, Dunn MJ, Fitzpatrick JM, Watson RW.

BJU Int. 2007 Feb;99(2):263-8. Epub 2006 Dec 1. Review.

18.

Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.

Downes MR, Byrne JC, Dunn MJ, Fitzpatrick JM, Watson RW, Pennington SR.

Biomarkers. 2006 Sep-Oct;11(5):406-16. Review.

PMID:
16966158
19.

Cholesterol in peripheral vascular disease--a suitable case for treatment?

Clark AL, Byrne JC, Nasser A, McGroarty E, Kennedy JA.

QJM. 1999 Apr;92(4):219-22.

PMID:
10396610
20.
21.

Defibrillation--a burning issue in coronary care units!

McNaughton GW, Wyatt JP, Byrne JC.

Scott Med J. 1996 Apr;41(2):47-8.

PMID:
8735502
22.

The influence of prostate size on cancer detection.

Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr.

Urology. 1995 Dec;46(6):831-6.

PMID:
7502425
23.
24.

From parturition to marathon: a 16-wk study of an elite runner.

Potteiger JA, Welch JC, Byrne JC.

Med Sci Sports Exerc. 1993 Jun;25(6):673-7.

PMID:
8321103
25.

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.

Scheffner M, Münger K, Byrne JC, Howley PM.

Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5523-7.

26.

Echocardiographic left ventricular wall thickness: a poor predictor of the severity of aortic valve stenosis.

Griffith MJ, Carey CM, Byrne JC, Coltart DJ, Jenkins BS, Webb-Peploe MM.

Clin Cardiol. 1991 Mar;14(3):227-31.

27.

Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA.

Schiffman MH, Bauer HM, Lorincz AT, Manos MM, Byrne JC, Glass AG, Cadell DM, Howley PM.

J Clin Microbiol. 1991 Mar;29(3):573-7.

28.

The effect of acute obstruction on ureteral function.

Crowley AR, Byrne JC, Vaughan ED Jr, Marion DN.

J Urol. 1990 Mar;143(3):596-9.

PMID:
2304180
29.

Relation between interatrial shunts and decompression sickness in divers.

Wilmshurst PT, Byrne JC, Webb-Peploe MM.

Lancet. 1989 Dec 2;2(8675):1302-6.

PMID:
2574256
30.

Neurological decompression sickness.

Wilmshurst PT, Byrne JC, Webb-Peploe MM.

Lancet. 1989 Apr 1;1(8640):731. No abstract available.

PMID:
2564546
32.
33.

Human cytomegalovirus (HCMV) enhances bovine papilloma virus (BPV) transformation in vitro.

Goldstein SC, Byrne JC, Rabson AS.

J Med Virol. 1987 Oct;23(2):157-64.

PMID:
2824682
34.

Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung.

Byrne JC, Tsao MS, Fraser RS, Howley PM.

N Engl J Med. 1987 Oct 1;317(14):873-8. No abstract available.

PMID:
2442608
35.

Enhancer-dependent expression of the rat preproinsulin gene in bovine papillomavirus type 1 vectors.

Sarver N, Muschel R, Byrne JC, Khoury G, Howley PM.

Mol Cell Biol. 1985 Dec;5(12):3507-16.

36.

The bovine papillomavirus distal "enhancer" is not cis essential for transformation or for plasmid maintenance.

Howley PM, Schenborn ET, Lund E, Byrne JC, Dahlberg JE.

Mol Cell Biol. 1985 Nov;5(11):3310-5.

37.

Localization and analysis of bovine papillomavirus type 1 transforming functions.

Sarver N, Rabson MS, Yang YC, Byrne JC, Howley PM.

J Virol. 1984 Nov;52(2):377-88.

38.

A bladder contractility constant.

Byrne JC, Tözeren A.

Am J Physiol. 1983 Nov;245(5 Pt 1):R673-7.

PMID:
6638214
39.

A stable bovine papillomavirus hybrid plasmid that expresses a dominant selective trait.

Law MF, Byrne JC, Howley PM.

Mol Cell Biol. 1983 Nov;3(11):2110-5.

40.
41.

Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells.

Turek LP, Byrne JC, Lowy DR, Dvoretzky I, Friedman RM, Howley PM.

Proc Natl Acad Sci U S A. 1982 Dec;79(24):7914-8.

42.

Biologic activity of oligomeric forms of SV40 DNA.

Israel MA, Byrne JC, Martin MA.

Virology. 1978 Jun 15;87(2):239-46. No abstract available.

PMID:
208273
43.

Characterization of supercoiled oligomeric SV40 DNA molecules in productively infected cells.

Martin MA, Howley PM, Byrne JC, Garon CF.

Virology. 1976 May;71(1):28-40. No abstract available.

PMID:
179203
44.

Physical map of the BK virus genome.

Howley PM, Khoury G, Byrne JC, Takemoto KK, Martin MA.

J Virol. 1975 Oct;16(4):959-73.

45.

Triplication of a unique genetic segment in a simian virus 40-like virus of human origin and evolution of new viral genomes.

Fareed GC, Byrne JC, Martin MA.

J Mol Biol. 1974 Aug 5;87(2):275-88. No abstract available.

PMID:
4372357
46.

Urethral compliance and its role in female voiding dysfunctions.

Gleason DM, Bottaccini MR, Reilly RJ, Byrne JC.

Invest Urol. 1973 Sep;11(2):83-91. No abstract available.

PMID:
4738013
47.

Patterns of simian virus 40 deoxyribonucleic acid transcription. II. In transformed cells.

Khoury G, Byrne JC, Takemoto KK, Martin MA.

J Virol. 1973 Jan;11(1):54-60.

48.

Energy loss during micturition.

Byrne JC, Bottaccini MR, Gleason DM.

Invest Urol. 1972 Nov;10(3):221-5. No abstract available.

PMID:
4640492
49.

Energy balance of voiding after cecal cystoplasty.

Gleason DM, Gittes RF, Bottaccini MR, Byrne JC.

J Urol. 1972 Aug;108(2):259-64. No abstract available.

PMID:
5047413
50.

The residual stream energy is a diagnostic index of male urinary outflow obstruction.

Gleason DM, Bottaccini MR, Reilly RJ, Byrne JC.

Invest Urol. 1972 Jul;10(1):72-7. No abstract available.

PMID:
5037972

Supplemental Content

Loading ...
Support Center